Global Staphylococcal Infection Drugs Market 2019-2023
- Published: Apr 2019
- Pages: 126
- SKU: IRTNTR31241
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global staphylococcal infection drugs market size will grow by USD 684.01 million during 2019-2023. The staphylococcal infection drugs market report provides a detailed analysis of the market by product (beta-lactams, peptides, quinolones, macrolides, and others) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including Allergan Plc, Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., and Pfizer Inc.
To identify growth opportunities in the staphylococcal infection drugs market, the market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2018-2023. Europe and North America will grow faster than the overall market. The growth of Asia and ROW will be slower than the global market.
Global Staphylococcal infection drugs market is expected to witness a CAGR of about 2.7% during the forecast period. Certain factors that are driving the market growth include increasing incidence of staphylococcal infections, rise in the use of antibiotics, and special drug designations.
Some of the key findings from our staphylococcal infection drugs market forecast report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the staphylococcal infection drugs market report.
The increased incidence of staphylococcal infections is due to the emergence of antibiotic-resistant staphylococcal strains such as Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA). The staphylococcal infections are known to develop in hospitals and other healthcare settings such as dialysis centers and nursing homes. According to the NHS, 846 cases of hospital-associated MRSA bloodstream infections were reported in the April 2017-March 2018 period in the UK. According to the CDC, it was estimated that more than 119,000 people in the US suffered from bloodstream Staphylococcus aureus in 2017. Furthermore, skin and soft tissue infections caused by staphylococcus. Hence, the increasing incidence of staphylococcal infections is driving the growth of the market.
Global staphylococcal infection drugs industry overview
The staphylococcal infection drugs market is witnessing the development of several improved screening methodologies involving the phenotypic and genotypic characterization of antimicrobial resistance present in bacterial isolates. High-throughput screening is one of the highly advanced screening methodologies and has undergone improvement in terms of the utilization of picodroplets for assessing and isolating MRSA in a label-free manner. Similarly, electro-chemical phenotyping is also gaining popularity for detecting antibiotic-resistant bacteria. These advanced screening technologies will help in identifying rare antibiotic-resistant mutants and aid in the development of novel drugs. The development of advanced technologies to screen antibiotic-resistant strains will be a critical trend that will have a positive impact on the growth of the staphylococcal infection drugs market.
The consumption of antibiotics including staphylococcal infection drugs has increased significantly especially in low and middle-income countries. They are an ideal option for the treatment of several infectious diseases. The therapeutic benefits and affordability of antibiotics have led to significant growth in consumption across the world. The rapid economic development in countries such as India, China, and Pakistan have further boosted the demand for antibiotic drugs. As a result of these factors, staphylococcal infection drugs market will register a CAGR of almost 3% during the forecast period.
Top companies covered in the staphylococcal infection drugs market research report
The global staphylococcal infection drugs market is fragmented. To help clients improve their market position, the staphylococcal infection drugs market report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this staphylococcal infection drugs market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
The report offers a detailed analysis of several leading staphylococcal infection drugs manufacturers, including:
- Allergan Plc
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Pfizer Inc.
Staphylococcal infection drugs market segmentation based on product
- Beta-lactams
- Peptides
- Quinolones
- Macrolides
- Others
The beta-lactams segment will account for the largest staphylococcal infection drugs market share. New drug approvals and the presence of promising beta-lactams in the pipeline are some of the factors contributing to the growth of the staphylococcal infection drugs market in this segment.
Staphylococcal infection drugs market segmentation based on geographic region
- Asia
- Europe
- North America
- ROW
With a complete study of the growth opportunities for companies, it has been identified that Asia will account for the largest staphylococcal infection drugs market share throughout the forecast period. Factors such as the increasing use of antibiotics in countries such as China and India, the high prevalence of staphylococcal infection, and the rising awareness about the need to manage and prevent infectious diseases will drive staphylococcal infection drugs market growth in this region.
Key highlights of the global staphylococcal infection drugs market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the staphylococcal infection drugs market during the next five years
- Precise estimation of the global staphylococcal infection drugs market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the staphylococcal infection drugs industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of staphylococcal infection drugs companies
We can help! Our analysts can customize the staphylococcal infection drugs market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Beta-lactams - Market size and forecast 2018-2023
- Peptides - Market size and forecast 2018-2023
- Quinolones - Market size and forecast 2018-2023
- Macrolides - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Allergan Plc
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Pfizer Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of vendors classification
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
